Developing an Effective Therapeutic HPV Vaccine to Eradicate Large Tumors by Genetically Fusing Xcl1 and Incorporating IL-9 as Molecular Adjuvants
Background: Human papillomavirus (HPV) is a prevalent infection affecting both men and women, leading to various cytological lesions. Therapeutic vaccines mount a HPV-specific CD8+ cytotoxic T lymphocyte response, thus clearing HPV-infected cells. However, no therapeutic vaccines targeting HPV are c...
Saved in:
| Main Authors: | Zhongjie Sun, Zhongyan Wu, Xuncheng Su |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/13/1/49 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extracellular vesicles derived from mature dendritic cells loaded with cDC1-specific chemokine XCL1 combined with chemotherapy-induced ICD for the treatment of castration-resistant prostate cancer
by: Zhongqiang Fan, et al.
Published: (2025-06-01) -
Effect of vaccination against HPV in the HPV-positive patients not covered by primary prevention on the disappearance of infection
by: Dominik Pruski, et al.
Published: (2025-04-01) -
Targeting Th9 cells in autoimmune diseases: a narrative review
by: Wang-Dong Xu, et al.
Published: (2025-07-01) -
IL-37 attenuated HPV induced inflammation of oral epithelial cells via inhibiting PI3K/AKT/mTOR
by: Yahong Shi, et al.
Published: (2024-12-01) -
HPV-driven cancers: a looming threat and the potential of CRISPR/Cas9 for targeted therapy
by: Atefeh Zamani Kermanshahi, et al.
Published: (2025-05-01)